Key facts
- This page summarizes William G. Richards's Form 4 filing for 23andMe Holding Co. (MEHCQ).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Sep 2023, 16:11.
William G. Richards - 15 Sep 2023 Form 4 Insider Report for 23andMe Holding Co. (MEHCQ)
- Reporting relationship
- Head of Therapeutics Discovery
- Issuer ticker
- MEHCQ
- Reported as of
- 15 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Sep 2023, 16:11:03 UTC
- Prior SEC filing
- 06 Sep 2023
- Next SEC filing
- 21 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Richards by Kathy Hibbs, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William G. Richards filed Form 4 for 23andMe Holding Co. (MEHCQ) on 19 Sep 2023.
Change
- Previous filing in this sequence was filed on 06 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ME
transaction
Class A common Stock
Award
- Transaction value
- $0
- Shares
- +344,050
- Change %
- +163%
- Price
- $0.000000
- Shares after
- 555,091
- Date
- 15 Sep 2023
- Ownership
- Direct
- Footnotes
- F1
ME
transaction
Class A common Stock
Award
- Transaction value
- $0
- Shares
- +115,641
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 670,732
- Date
- 15 Sep 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ME
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +166,394
- Change %
- Price
- $0.000000
- Shares after
- 166,394
- Date
- 15 Sep 2023
- Ownership
- Direct
- Underlying class
- Class A common Stock
- Underlying amount
- 166,394
- Exercise price
- $1.10
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Grant of restricted stock units (the "RSUs") under the 23andMe Holding Co. Amended and Restated 2021 Incentive Equity Plan (the "Plan"). The RSUs vest equally in 1/12 quarterly installments commencing on February 20, 2024. The vesting of the RSUs is subject to continued service for 23andMe Holding Co. (the "Company"), the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
Footnote F2
Grant of RSUs under the Company's Plan. The RSUs vest in full on August 20, 2024. The vesting of the RSUs is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of the Company.
Footnote F3
Grant of stock options under the Plan. The stock options vest equally in 1/36 monthly installments commencing on October 15, 2023. The vesting of the options is subject to continued service for the Company, the terms and conditions of the applicable award agreement, and applicable tax withholding obligations.